07:49 AM EST, 11/20/2025 (MT Newswires) -- Cannabinoid company Vext Science ( VEXTF ) , which rose 6.25% on Wednesday, reported a widened net loss after taxes in the third quarter even as revenue increased.

For the three-months ended Sept. 30, the company on Thursday reported net loss after taxes of US$2.6 million compared with $2.5 million, a year earlier.

Revenue increased to US$12.7 million in the quarter compared with $9.0 million, a year-ago, missing consensus estimate compiled by FactSet of US$13.3 million.

"For the remainder of 2025, we expect continued operational momentum and remain focused on maximizing performance across our five Ohio dispensaries, while advancing construction and licensing of the three additional locations planned for 2026," said Vext Science ( VEXTF ) Chief Executive Eric Offenberger. "We continue to generate strong cash flow, and we expect Q4 cash flow to improve as we work through the inventory built in Q3."

Shares of the company closed up C$0.015 to $0.255 on Thursday on the Canadian Securities Exchange.